Company intelligence / Profile preview

Reach Orthopaedics

Halifax, Nova Scotia, Canadareachortho.ca ↗

Ownership: Private
Development stage: Preclinical

Overview

Reach Orthopaedics has developed a novel subacromial spacer implant with a fixation arm to the scapular spine designed to restore shoulder alignment and function while reducing chronic pain in patients with massive irreparable rotator cuff tears. The device has received FDA Breakthrough Device designation and an in-human feasibility study is planned for 2025. No published clinical results yet.

Therapeutic areas: OtherRheumatology
Modalities: Device (shoulder implant)
Industry: Implantable Medical Devices

Partnerships

UCeed Health Fund (University of Calgary investment program)

Beyond the preview

Go deeper on Reach Orthopaedics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reach Orthopaedics.

Explore the full profile